What is the catalog number for GCN2/EIF2AK4 Rabbit Polyclonal Antibody?

The catalog number for GCN2/EIF2AK4 Rabbit Polyclonal Antibody is orb99190.

What sizes are available for GCN2/EIF2AK4 Rabbit Polyclonal Antibody?

GCN2/EIF2AK4 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is GCN2/EIF2AK4 Rabbit Polyclonal Antibody in stock?

GCN2/EIF2AK4 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

GCN2/EIF2AK4 Rabbit Polyclonal Antibody

Anti-GCN2/EIF2AK4 Antibody. Tested in WB applications. This antibody reacts with Mouse, Rat.

Product Specifications

Product Name Alternative

Eukaryotic translation initiation factor 2-alpha kinase 4; 2.7.11.1; GCN2-like protein; mGCN2; Eif2ak4; Gcn2, Kiaa1338

UniProt

Q9QZ05

Reactivity

Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence in the middle region of mouse GCN2, different from the related rat sequence by one amino acid.

Target

EIF-2-alpha kinase GCN2

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Epigenetics & Chromatin, Molecular Biology, Protein Biochemistry, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Mouse, Rat

Form

Lyophilized

Molecular Weight

94 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.